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Sunlight-induced vitamin D, synthesis in the skin is the major source of vitamin D, but data on the relationship of sun-related
behaviour with vitamin D and parathyroid hormone (PTH) levels are relatively sparse. We evaluated whether habitual sun
exposure is associated with 25-hydroxyvitamin D (25[OH]D) and PTH levels and whether there exist seasonal variations. We
examined 111 hypertensive patients in Austria (latitude 47◦ N). Frequent sunbathing at home and outdoor sports were associated
with higher 25(OH)D levels (P < 0.05 for both). Red or blond scalp hair as a child, memory of sunburns, preferring sunbathing,
frequent stays on the beach or in open-air pools, and solarium use were associated with lower PTH levels (P < 0.05 for all). Multiple
linear regression analyses including age, sex, and body mass index showed that sun exposure score was significantly associated with
25(OH)D (beta coeﬃcient = 0.27; P = 0.004) and by trend with PTH (beta coeﬃcient = −0.16; P = 0.09). These associations
were more prominent in summer in which 25(OH)D levels were significantly higher compared to winter. Translation of these
findings into recommendations for the prevention and treatment of vitamin D deficiency remains a challenge for the future.
1. Introduction
Vitamin D deficiency is considered a widespread public
health problem because vitamin D is important for musculo-
skeletal health and probably also for various other chronic
diseases including cardiovascular and metabolic diseases,
cancer, and infections and autoimmune diseases [1–10]. A
profound role of vitamin D status for human health is fur-
ther supported by pathophysiological evidence showing
that the vitamin D receptor (VDR) is almost ubiquitously
expressed [1–10]. Furthermore, vitamin D metabolites reg-
ulate approximately three percent of the human genome
[10]. The currently high worldwide prevalence of vitamin
D deficiency is mainly attributable to low sunlight exposure
of the skin [1–3, 11]. Previous studies suggest that ∼80%
of vitamin D is obtained by ultraviolet-B- (UV-B-) induced
vitamin D synthesis in the skin whereas diet makes only a
minor contribution [12]. Consequently, there exists a sig-
nificant seasonal variation with highest 25-hydroxyvitamin
D (25[OH]D) levels at the end of summer [12–15]. UV-B-
induced vitamin D synthesis in the skin is, however, influ-
enced by various factors such as skin pigmentation, age,
and increasing distance from the equator or air pollution,
which are all associated with reduced dermal vitamin D
production [1, 12–18]. Time of day and exposed skin are
also of relevance. Hence, there remain various ambiguous
issues regarding the impact of habitual sunlight exposure on
vitamin D status. Previous data on this topic are relatively
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sparse and partially inconsistent regarding the relationship
of sun exposure-related behaviour and vitamin D status [19–
29]. Such data are, however, clinically relevant, also in light
of the fact that current recommendations for the prevention
and treatment of vitamin D status mainly focus on nutri-
tional and supplemental vitamin D leaving many physicians
unsecure on how to deal with advices regarding the role
of habitual sunlight exposure [2, 30, 31]. We therefore
addressed the relationship of sun-related behaviour, assessed
by a previously published questionnaire, with 25(OH)D
levels in an Austrian cohort of hypertensive patients derived
from the Graz Endocrine Causes of Hypertension (GECOH)
Study [32, 33]. Our specific aims were to test (i) whether
a sun exposure score is associated with 25(OH)D levels,
(ii) whether this relationship is diﬀerent in summer and
winter, and (iii) to evaluate seasonal diﬀerences in 25(OH)D
levels. In addition, we also tested whether plasma levels of
parathyroid hormone (PTH), which increases in vitamin D
deficiency, are associated with sun exposure, season of blood
draw and 25(OH)D.
2. Materials and Methods
2.1. Study Population. The GECOH study is a diagnos-
tic accuracy study of the aldosterone-to-active-renin ratio
(AARR) in screening for primary aldosteronism (PA). The
study protocol as well as baseline data of the GECOH study
have been published previously [33, 34]. In this single-center
study at the Medical University of Graz, Austria (latitude:
47◦ north), we included adult hypertensive patients (age
≥ 18 years), who were routinely referred to our outpatient
clinic for screening for endocrine hypertension. All patients
underwent standardized procedures for PA and endocrine
hypertension diagnostics, as described elsewhere [33, 34].
Height and weight determinations were performed wearing
light clothes and no shoes, and body mass index (BMI) was
calculated according to weight (in kg) divided by the square
of height (in meters). Systolic and diastolic blood pressures
were measured twice by the method of Korotkoﬀ and the
mean values of both measurements were recorded. Winter
season was classified from October to March and summer
season was classified from April to September. We obtained
written informed consent from all study participants, and the
GECOH study was approved by the ethics committee at the
Medical University of Graz, Austria.
2.2. Laboratory Methods. All laboratory procedures have
been previously described in detail [33, 34]. Fasting blood
samplings were performed between 8.00 and 11:00 am.
Laboratory measurements were either performed on a daily
or weekly basis. Wemeasured serum 25(OH)D by a chemilu-
minescence assay (IDS, iSYS 25-hydroxyvitamin D; Immun-
odiagnostic systems Ltd., Boldon, England) on an IDS-
iSYS multidiscipline automated analyser. Within-day and
interday coeﬃcients of variation (CV) were 5.5 to 12.1%,
and 8.9 to 16.9%, respectively. Plasma concentrations of
intact PTH were determined by electrochemiluminescence
immunoassay (ECLIA) on an Elecsys 2010 (Roche Diag-
nostics, Mannheim, Germany), with a normal range of 15–
65 pg/mL and an interassay CV of 5.7–6.3%. Serum calcium
was determined by the Roche/Hitachi cobas c system ana-
lyzer (Roche Diagnostics, Mannheim, Germany).
2.3. Sun Behaviour Questionnaire. We used a German lan-
guage questionnaire on sun-related behaviour that was ini-
tially developed to assess the relationship of UV exposure
and melanocytic nevi [32]. In detail, this evaluation (with a
scoring system for the answers in parenthesis) includes the
questions number 1 to 4, which concern skin reactions to
sun or skin type, and the questions number 5a to 5i, which
concern detailed sun-specific behaviour. Question 1: What is
your personal relationship with the sun? (I avoid the sun = 0;
I like the sun, but after a short time I try to protect myself
or search for a shady place = 1; I love the sun and being
unprotected I bear the sun for a while = 2; I could be in
the sun forever = 3). Question 2: How would be your skin
reaction on the first summer sun, if you would be in the
midday sun for 1 hour without sun cream and without being
browned by the sun before? (the next day I would have
a painful sunburn and no browning after one week = 0;
the next day I would have a painful sunburn and a slight
browning after one week = 1; the next day I would have a
slight sunburn and a moderate browning of the skin after
one week = 2; the next day I would have no sunburn and
a significant browning of the skin after one week = 3). Ques-
tion 3: How was your scalp hair as a child? (red or blond = 0,
brown or black = 1). Question 4a: How many sunburns can
you describe in detail by geographical region, by body area,
and by year? (no sunburn = 0; one sunburn = 1; at least two
sunburns = 2). Question 4b: Did you ever have sunburns
even if you cannot remember the detailed circumstances?
(no = 0; yes = 1). Question 5a: Did you have frequent stays on
the beach or in open-air pools? (no = 0; yes = 1). Question 5b:
Did you have frequent sunbathing at home? (no = 0; yes = 1).
Question 5c: Did you do regular gardening work? (no = 0,
yes = 1). Question 5d: Did you do water sports or shipping?
(no = 0, yes = 1). Question 5e: Did you do other outdoor
sports? (no = 0; yes = 1). Question 5f: Did you do professional
outdoor work? (no = 0; yes = 1). Question 5g: How many
holidays did you have in sunny countries? (none = 0; one to
three = 1; four to ten = 2; more than ten = 3). Question 5h:
How often do you go to a solarium? (never = 0; sometimes =
1; frequently = 2). Question 5i: Have you ever been treated
by light or UV therapy due to skin disease? (no = 0; yes = 1).
According to the original publication of that questionnaire
we calculated a “sun exposure score” as the sum of the scores
of questions number 5a to 5i [32].
2.4. Statistical Analyses. Continuous data are presented as
means ± standard deviation and categorical variables are
presented as percentages. Student’s t-test and analysis of
variance (ANOVA) with P for trend was used to test for
group diﬀerences in 25(OH)D or PTH levels. We performed
Pearson’s correlation analyses of “sun exposure score” with
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Table 1: Baseline characteristics of the GECOH study.
Variable
Number 111
Age (years) 49.1 ± 15.6
Females (%) 55.0
Summer season (%) 57.7
Body mass index (kg/m2) 28.3 ± 6.0
25-hydroxyvitamin D (ng/mL) 33 ± 17
Parathyroid hormone (pg/mL) 46 ± 17
Serum calcium (mmol/L) 2.34 ± 0.09
Systolic blood pressure (mm Hg) 153 ± 24
Diastolic blood pressure (mm Hg) 95 ± 14
Primary aldosteronism (%) 3.6
Continuous data are presented as means ± standard deviation, and categor-
ical data are presented as percentages.
25(OH)D and PTH concentrations. In addition, we per-
formed multiple linear regression analyses with 25(OH)D
levels or PTH as the dependent variable and “sun exposure
score” as well as the possible confounders age (years), sex
(male = 0, female = 1), and BMI (kg/m2) as independent
variables. These above-described correlation and regression
analyses were also performed in subgroups of patients strat-
ified by season of blood draw. A P value below 0.05 was
considered statistically significant and SPSS version 16.0 was
used for statistical analyses.
3. Results
Between February 2009 and February 2011 we examined 175
Caucasian patients of the GECOH study. All study partici-
pants were asked to fill out a sun behaviour questionnaire.
Questionnaires were returned by 115 patients (66% of the
entire study population). Of these 115 patients we excluded
4 participants due to vitamin D supplementation, leaving
111 participants who were included into the present work.
Baseline characteristics of this study cohort are presented
in Table 1. Serum 25(OH)D levels were below 30 ng/mL
in 53 patients (47.7%) and below 20 ng/mL in 25 patients
(22.5%) (to convert 25[OH]D in ng/mL to nmol/L multiply
by 2.496). In Pearson correlation analysis we observed a
significant inverse association of 25(OH)D and PTH (r =
−0.20; P = 0.04). Associations of 25(OH)D and PTH
with answer scores of the sun behaviour questionnaire are
shown in Tables 2 and 3, respectively. 25(OH)D levels were
significantly increased in patients who reported on outdoor
sports and sunbathing at home (see Table 2). PTH levels were
significantly decreased in participants with a red or blond
scalp hair as a child, in those who could recall sunburns and
in those who like sunbathing and who reported on frequent
stays at the beach or open-air pools and on solarium use
(see Table 3). Sun exposure score was significantly associated
with higher 25(OH)D levels (r = 0.27; P = 0.005) and
by trend with lower PTH levels (r = −0.17; P = 0.07).
In multiple linear regression analysis sun exposure score
remained a significant predictor of higher 25(OH)D levels
(beta coeﬃcient = 0.27; P = 0.004), and this association was
stronger than for BMI (beta coeﬃcient = −0.23; P = 0.01),
age (beta coeﬃcient = −0.20; P = 0.03), or gender (beta
coeﬃcient = 0.03; P = 0.73). Multiple linear regression
analysis for PTH as the dependent variable showed only
a nonsignificant trend for an inverse association with the
sun exposure score (beta coeﬃcient = −0.16; P = 0.09).
In that analysis there was no association with gender (beta
coeﬃcient = 0.06; P = 0.55), but age (beta coeﬃcient =
0.34; P < 0.001) and BMI (beta coeﬃcient = 0.20; P = 0.03)
were significantly associated with PTH levels.
Serum levels of 25(OH)D (in ng/mL) were significantly
higher in summer compared to winter (37 ± 18 versus 28 ±
13; P = 0.003) but there was no statistically significant diﬀer-
ence in PTH levels in summer (43 ± 15 pg/mL) compared to
winter (49 ± 20 pg/mL; P = 0.12). Season stratified analyses
showed that in summer, sun exposure score was significantly
associated with both 25(OH)D (r = 0.27; P = 0.03) and PTH
(r = −0.36; P = 0.004). By contrast, there was no significant
association in winter, neither with 25(OH)D (r = 0.16;
P = 0.27) nor with PTH (r = 0.06; P = 0.67). Multiple liner
regression analyses showed that sun exposure score was only
by trend associated with 25(OH)D levels in summer (beta
coeﬃcient = 0.21; P = 0.09) and there was also no significant
association in winter (beta coeﬃcient= 0.18; P = 0.25). Sun
exposure score, however, predicted PTH levels in summer
(beta coeﬃcient = −0.32; P = 0.02) but not in winter (beta
coeﬃcient = −0.01; P = 0.98).
There were no significant diﬀerences in 25(OH)D levels
between women (34 ± 17 ng/mL) and men (33 ± 16 ng/mL;
P = 0.90). PTH levels were also similar in both sexes
(women: 47± 19 pg/mL andmen: 45± 16 pg/mL; P = 0.52).
4. Discussion
In this cohort of hypertensive patients we have shown
that habitual sunlight exposure is associated with higher
25(OH)D levels and by trend with lower PTH levels. These
associations were more prominent in the summer season in
which 25(OH)D levels were significantly higher compared to
winter.
Our work is, to the best of our knowledge, the first to
address the relationship of habitual sunlight exposure with
25(OH)D and PTH levels in Central Europe. As expected,
we found that higher self-reported sunlight exposure was
associated with higher 25(OH)D levels, independent of the
possible confounders age, sex, and BMI. These data are in
line with previous studies in Southern and Northern Europe
as well as other regions of the world, which also reported on
a significant eﬀect of sunlight exposure on 25(OH)D levels
[19–21, 24–29]. By contrast, some investigations did not find
a profound eﬀect of sunlight-related behaviour on vitamin
D status [22, 23]. Hence, although it is well established
that sunlight-induced vitamin D synthesis in the skin is the
major source for vitamin D, the precise impact of habitual
sunlight exposure on vitamin D status remains to be further
explored [15–18]. This issue is relatively complex because the
eﬃcacy of dermal vitamin D synthesis can be modulated by
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Table 2: Associations of 25-hydroxyvitamin D with answers from a sun behaviour questionnaire.
Question number Question content
Answer scores
P value
0 1 2 3
1 Personal sun relationship
28 ± 6 31 ± 15 37 ± 19 38 ± 23 0.06
n = 8 n = 60 n = 34 n = 9
2 Skin reaction to sun
28 ± 12 33 ± 16 35 ± 16 33 ± 20 0.25
n = 17 n = 25 n = 49 n = 20
3 Scalp hair as a child
33 ± 15 34 ± 17 0.79
n = 42 n = 69
4a Memory of sunburns
33 ± 17 34 ± 16 34 ± 18 0.68
n = 51 n = 39 n = 21
4b Ever sunburns
18 ± 8 34 ± 17 0.07
n = 4 n = 107
5a Beach or open-air pools
31 ± 14 37 ± 19 0.05
n = 63 n = 48
5b Sunbathing at home
31 ± 14 38 ± 21 0.04
n = 73 n = 38
5c Gardening
35 ± 17 32 ± 16 0.37
n = 68 n = 43
5d Water sports or shipping
34 ± 17 31 ± 13 0.55
n = 99 n = 12
5e Other outdoor sports 30 ± 15 40 ± 18 0.003
n = 74 n = 37
5f Outdoor work 32 ± 16 36 ± 18 0.29
n = 85 n = 26
5g Holidays in sunny countries 29 ± 15 30 ± 16 34 ± 16 36 ± 17 0.07
n = 13 n = 23 n = 21 n = 54
5h Solarium 33 ± 17 34 ± 16 0.92
n = 92 n = 19 n = 0
5i Light or UV therapy 33 ± 16 35 ± 24 0.87
n = 106 n = 5
25-hydroxyvitamin D data are shown in ng/mL as means ± standard deviation.
P values are derived from either Student’s t-test or from analysis of variance (ANOVA) with P for trend.
various factors [15–18]. Important factors are, for example,
latitude and weather, which underlines the importance of
our study that significantly adds to the knowledge from
previous studies derived from other geographical regions.
It should be acknowledged that UV-B-induced vitamin D
synthesis becomes less eﬀective with increasing distance from
the equator resulting in the inability to produce vitamin
D during winter season in Northern Europe. Consequently,
there exists a seasonal variation of 25(OH)D that was also
observed in our work and that, likewise, contributes to a
significant attenuation of the association of outdoor activities
and 25(OH)D in winter, as reported in a Swedish cohort
[23]. This reduced dermal vitamin D synthesis in winter may
underlie our observation that in season-stratified analyses
of the GECOH study the correlation of sun exposure score
with 25(OH)D was only significant in summer but not in
winter. Higher skin pigmentation has also been reported
to impair vitamin D synthesis in the skin, but we did not
observe diﬀerences in 25(OH)D levels according to answers
on skin type or skin reactions to the sun [15–18]. This
may be due to the fact that we studied a Caucasian cohort
with a relatively homogenous skin type. Regarding specific
questions on sun-related behaviour, we observed that in
particular outdoor sports and sunbathing at home were
associated with higher 25(OH)D levels. We are well aware
that this is not a very detailed assessment of sun exposure
as it was done in some previous studies, but our data
may provide good insight into the relationship of daily life
behaviour with vitamin D status. Although our findings do
not prove causality, they might be helpful for developing
recommendations to change lifestyle in order to improve
vitamin D status. In this context, it is important to note that
previous studies have already performed detailed evaluations
of the eﬀect of artificial UV-B exposure on 25(OH)D levels
[15–18, 35–38]. According to such experiments, Webb et al.
calculated that when wearing knee-length shorts and a T-
shirt with sleeves to mid upper arms at a latitude of 30 to 60◦,
midsummer noontime sunlight exposure for ∼30 minutes
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Table 3: Associations of parathyroid hormone with answers from a sun behaviour questionnaire.
Question number Question content
Answer scores
P value
0 1 2 3
1 Personal sun relationship
50 ± 17 49 ± 19 41 ± 14 42 ± 19 0.04
n = 8 n = 60 n = 34 n = 9
2 Skin reaction to sun
41 ± 16 50 ± 16 45 ± 18 47 ± 19 0.71
n = 17 n = 25 n = 49 n = 20
3 Scalp hair as a child
41 ± 14 49 ± 19 0.03
n = 42 n = 69
4a Memory of sunburns
50 ± 19 42 ± 17 43 ± 14 0.048
n = 51 n = 39 n = 21
4b Ever sunburns
53 ± 32 45 ± 17 0.38
n = 4 n = 107
5a Beach or open air pools
50 ± 16 40 ± 17 0.003
n = 63 n = 48
5b Sunbathing at home
46 ± 18 46 ± 16 0.97
n = 73 n = 38
5c Gardening
46 ± 17 46 ± 18 0.88
n = 68 n = 43
5d Water sports or shipping
46 ± 18 44 ± 11 0.60
n = 99 n = 12
5e Other outdoor sports
46 ± 17 45 ± 18 0.71
n = 74 n = 37
5f Outdoor work
44 ± 17 50 ± 19 0.15
n = 85 n = 26
5g Holidays in sunny countries
51 ± 16 43 ± 19 52 ± 21 43 ± 15 0.28
n = 13 n = 23 n = 21 n = 54
5h Solarium
48 ± 18 36 ± 12 0.006
n = 92 n = 19 n = 0
5i Light or UV therapy
46 ± 18 41 ± 12 0.58
n = 106 n = 5
Parathyroid hormone data are shown in ng/mL as means ± standard deviation.
P values are derived from either Student’s t-test or from analysis of variance (ANOVA) with P for trend.
(range 16–49 minutes) three times a week should be enough
for achieving 25(OH)D levels above 20 ng/mL [35–37]. Such
estimations could be a starting point for sunlight exposure
advice. Current recommendations regarding sunlight expo-
sure are, however, insuﬃcient when considering the high
prevalence of vitamin D deficiency. To address this issue
Farrar et al. showed that adhering to the sunlight exposure
recommendations of the UK Health Protection Agency fails
to achieve a suﬃcient vitamin D status in UK adults of South
Asian origin [38]. Apart from this, it should be taken into
account that according to observational data a late summer
25(OH)D level of at least ∼32 ng/mL is required to ensure
25(OH)D levels above 20 ng/mL throughout winter [36, 39].
Considering that there is an ongoing debate on the optimal
25(OH)D levels and in view of the potential adverse eﬀects
of UV exposure on diseases like skin cancer it is challenging
to formulate recommendations regarding sunlight exposure
for the prevention and treatment of vitamin D deficiency
[35–40]. We believe that beyond giving detailed advice for
minutes of sunlight exposure according to factors such as
skin type, daytime, latitude, and clothing, it might also
be very practical to raise more general recommendations
regarding casual sunlight exposure as part of daily activities
(e.g., recommending more outdoor sports activities). Con-
cerning this, we believe that our data on habitual sunlight
exposure and 25(OH)D may be helpful, and we strongly
recommend further studies to evaluate the relationship of
casual sunlight exposure with vitamin D status and to test
whether simple advice for lifestyle changes are eﬀective for
fighting vitamin D deficiency. A previous study, however,
indicates that simple advice for more sunlight exposure are
by far less eﬀective than prescription of vitamin D supple-
mentation [41].
In addition to our findings on 25(OH)D we observed
similar results for an inverse association of sun exposure and
PTH levels. This result was expected due to what is known
and in our study we also confirm an inverse association
of 25(OH)D and PTH. Previous studies that specifically
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evaluated the impact of sun-related behaviour on PTH levels
are, however, rare [42, 43]. Our observed inverse relationship
of PTH and sun exposure was particularly pronounced in
summer season with absolutely no association in winter.
Specifically, we found that red or blond scalp hair as a child,
memory of sunburns, and frequent stays at the beach or
open-air pools were associated with low PTH levels. Inter-
estingly, study participants who went to a solarium had also
significantly decreased PTH concentrations while 25(OH)D
levels were not meaningfuly diﬀerent. Whereas previous
investigations have already demonstrated significant eﬀects
of solaria on vitamin D status we show that there is also
an association with PTH levels [44]. The clinical relevance
of our PTH findings are underlined by the fact that rising
PTH levels are a hallmark of vitamin D deficiency and have
been associated with adverse outcomes including mortality
and cardiovascular events [1–3, 44–49]. Apart from this,
high PTH levels are deleterious for bone health and are also
associated with calcific aortic stenosis, the metabolic syn-
drome, and cancer risk [50–55]. In this context, our findings
provide evidence that sunlight exposure in summer might be
useful for the treatment of inappropriate high PTH levels,
a hypothesis that deserves further investigation. Although
PTH levels are significantly and inversely correlated with
25(OH)D it should be noted that the molecular eﬀects of
PTH and vitamin D are largely independent of each other
[3, 10, 56].
Our results are limited by the observational design of
our study that limits conclusions regarding causality. Fur-
thermore, our questionnaire on sun-related behaviour did
not include evaluations for detailed calculations of UV-B
exposure or some modulating and relevant factors such as
sunscreen use or specific assessment of skin type. Although
we excluded study participants who reported on vitamin
D supplement use we did not evaluate nutritional vitamin
D intake. Another possible drawback is the use of the IDS
immunoassay that is not the gold standard method for the
determination of 25(OH)D levels.
In conclusion, we found that habitual sun exposure in
Austria is associated with higher 25(OH)D levels and, in
summer, also with reduced PTH levels. These data on the
relationship of habitual sun exposure with vitamin D and
PTH status underline the importance of lifestyle behaviour
for maintenance of physiologic vitamin D and PTH status.
Translation of these findings into recommendations for
changes in lifestyle to prevent and treat vitamin D deficiency
remains a challenge for the near future.
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